Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis

Background/Aims: The gastric extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (gastric MALT lymphoma) are mostly related to Helicobacter pylori infections. However, chromosomal aberration involving translocation t(11;18) is also frequently reported in these patients. M...

Full description

Bibliographic Details
Main Authors: Hana Jung, Da Wit Shin, Dae Young Cheung, Han Hee Lee, Jin Il Kim, Soo-Heon Park, Tae Jung Kim
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2023-01-01
Series:The Korean Journal of Gastroenterology
Subjects:
Online Access:https://www.kjg.or.kr/journal/view.html?uid=5883&vmd=Full
_version_ 1797271200428195840
author Hana Jung
Da Wit Shin
Dae Young Cheung
Han Hee Lee
Jin Il Kim
Soo-Heon Park
Tae Jung Kim
author_facet Hana Jung
Da Wit Shin
Dae Young Cheung
Han Hee Lee
Jin Il Kim
Soo-Heon Park
Tae Jung Kim
author_sort Hana Jung
collection DOAJ
description Background/Aims: The gastric extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (gastric MALT lymphoma) are mostly related to Helicobacter pylori infections. However, chromosomal aberration involving translocation t(11;18) is also frequently reported in these patients. Methods: The study was a retrospective review and analysis of electronic medical records to assess the factors which affect complete remission (CR) in patients with gastric MALT lymphoma. Based on the medical records, subjects with gastric MALT lymphoma were enrolled consecutively from January 2004 to December 2021. Results: Among the 77 subjects who were found with gastric MALT lymphoma in the database, 65 cases with complete records were analyzed. Of these, 66.2% (43/65) were H. pylori positive. Genetic analyses for t(11:18) were done on 41 subjects. The t(11:18) chromosomal translocation with MALT1:BIRC3 fusion was found in 31.7% (13/41) of the subjects. With H. pylori eradication therapy, 75% (21/28) of the subjects without t(11:18) achieved CR. However, only 23.1% (3/13) subjects with t(11:18) could achieve CR (p-value= 0.009). In the H. pylori-positive group, 85.7% (18/21) subjects without t(11:18) achieved CR with eradication therapy, but 71.4% (5/7) subjects with t(11:18) failed to achieve CR (p-value=0.004). In the H. pylori-negative group, 42.3% (3/7) of the subjects without t(11:18) achieved CR with eradication therapy. However, 83.3% (5/6) of H. pylori-negative subjects with t(11:18) failed to achieve CR with eradication therapy and needed additional radiotherapy (p-value=0.396). Conclusions: H. pylori negativity and the presence of t(11:18) were both risk factors for failure to achieve CR with H. pylori eradication therapy as the first line of treatment.
first_indexed 2024-03-07T13:58:21Z
format Article
id doaj.art-a9a5038b023e47139fa6473053ee82ee
institution Directory Open Access Journal
issn 1598-9992
2233-6869
language English
last_indexed 2024-03-07T13:58:21Z
publishDate 2023-01-01
publisher Jin Publishing & Printing Co.
record_format Article
series The Korean Journal of Gastroenterology
spelling doaj.art-a9a5038b023e47139fa6473053ee82ee2024-03-07T07:22:46ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922233-68692023-01-01811293510.4166/kjg.2022.129Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective AnalysisHana Jung0Da Wit Shin1Dae Young Cheung2https://orcid.org/0000-0003-4150-3555Han Hee Lee3Jin Il Kim4Soo-Heon Park5Tae Jung Kim6Departments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartments of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground/Aims: The gastric extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (gastric MALT lymphoma) are mostly related to Helicobacter pylori infections. However, chromosomal aberration involving translocation t(11;18) is also frequently reported in these patients. Methods: The study was a retrospective review and analysis of electronic medical records to assess the factors which affect complete remission (CR) in patients with gastric MALT lymphoma. Based on the medical records, subjects with gastric MALT lymphoma were enrolled consecutively from January 2004 to December 2021. Results: Among the 77 subjects who were found with gastric MALT lymphoma in the database, 65 cases with complete records were analyzed. Of these, 66.2% (43/65) were H. pylori positive. Genetic analyses for t(11:18) were done on 41 subjects. The t(11:18) chromosomal translocation with MALT1:BIRC3 fusion was found in 31.7% (13/41) of the subjects. With H. pylori eradication therapy, 75% (21/28) of the subjects without t(11:18) achieved CR. However, only 23.1% (3/13) subjects with t(11:18) could achieve CR (p-value= 0.009). In the H. pylori-positive group, 85.7% (18/21) subjects without t(11:18) achieved CR with eradication therapy, but 71.4% (5/7) subjects with t(11:18) failed to achieve CR (p-value=0.004). In the H. pylori-negative group, 42.3% (3/7) of the subjects without t(11:18) achieved CR with eradication therapy. However, 83.3% (5/6) of H. pylori-negative subjects with t(11:18) failed to achieve CR with eradication therapy and needed additional radiotherapy (p-value=0.396). Conclusions: H. pylori negativity and the presence of t(11:18) were both risk factors for failure to achieve CR with H. pylori eradication therapy as the first line of treatment.https://www.kjg.or.kr/journal/view.html?uid=5883&vmd=Fullstomachextranodal marginal zone b cell lymphoma of malt typet(11:18)
spellingShingle Hana Jung
Da Wit Shin
Dae Young Cheung
Han Hee Lee
Jin Il Kim
Soo-Heon Park
Tae Jung Kim
Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
The Korean Journal of Gastroenterology
stomach
extranodal marginal zone b cell lymphoma of malt type
t(11:18)
title Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
title_full Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
title_fullStr Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
title_full_unstemmed Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
title_short Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis
title_sort clinical impact assessment and utilization prospects of the t 11 18 chromosomal translocation in gastric malt lymphoma in koreans a single center retrospective analysis
topic stomach
extranodal marginal zone b cell lymphoma of malt type
t(11:18)
url https://www.kjg.or.kr/journal/view.html?uid=5883&vmd=Full
work_keys_str_mv AT hanajung clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT dawitshin clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT daeyoungcheung clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT hanheelee clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT jinilkim clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT sooheonpark clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis
AT taejungkim clinicalimpactassessmentandutilizationprospectsofthet1118chromosomaltranslocationingastricmaltlymphomainkoreansasinglecenterretrospectiveanalysis